Tag: mental health

Daily step counts before, after COVID-19 pandemic

Editor's Note This study from Vanderbilt University Medical Center, Nashville, Tennessee, finds a consistent, widespread, and significant decline in activity following the onset of COVID-19 in the US. The analysis included 5,443 participants who wore a digital device tracking physical activity (Fitbit) for at least 10 days each month. Daily…

Read More

By: Judy Mathias
March 23, 2023
Share

ECRI: Pediatric mental health crisis tops patient safety concerns

Editor's Note ECRI, on March 13, released its annual Top 10 Patient Safety Concerns, which identifies potential sources of danger for patients and healthcare staff. ECRI also provides detailed steps that organizations can take to prevent adverse incidents. Many of the concerns on the list are exacerbated by ongoing staffing…

Read More

By: Judy Mathias
March 13, 2023
Share

Association of COVID-19 containment policies with children’s mental health

Editor's Note This study led by researchers at Weill Cornell Medicine, New York Presbyterian, New York City, and the University of California, Berkeley, finds that family financial disruptions caused by COVID-19 containment policies worsened children’s mental health. This analysis included a nationwide cohort of 6,030 US children aged 10 to…

Read More

By: Judy Mathias
March 13, 2023
Share

Surveys show pandemic’s effect on mental health

Editor's Note Although most people have largely returned to normal activities, mental health is still a concern, finds surveys conducted between March 2020 and September 2022 by Pew Research Center and other organizations. Among the findings: 41% of adults experienced high levels of psychological distress at some point in the…

Read More

By: Judy Mathias
March 6, 2023
Share

Study: Procrastination harms mental, physical health

Editor's Note This study of Swedish university students finds that procrastination is associated with a range of subsequent adverse health outcomes. This analysis included data on 3,525 university students from 8 universities in the greater Stockholm area and Orebro. They were followed-up at 3 time points, and 16 self-reported health…

Read More

By: Judy Mathias
January 26, 2023
Share

Gen Z’s view of healthcare

Editor's Note A recent report from management consulting firm Oliver Wyman finds that Generation Z’s view of healthcare differs from its predecessors, the January 24 Becker’s Hospital Review reports. The report was written after 2 years of focus groups and surveys of 10,000 individuals in the US and UK who…

Read More

By: Judy Mathias
January 25, 2023
Share

New ACS guideline helps trauma centers screen patients for mental health, substance misuse

Editor's Note On January 10, the American College of Surgeons (ACS) reported on a new best practice guideline released to help healthcare professionals screen trauma patients for mental health disorders and substance misuse. Because alcohol and substance misuse problems are prevalent and increasing in trauma patients, this guideline is an…

Read More

By: Judy Mathias
January 12, 2023
Share

Mental healthcare demand at Mass Gen caused ‘unprecedented’ backlog

Editor's Note Massachusetts General Hospital (Mass Gen) in Boston this summer saw an “unprecedented” surge in demand for mental healthcare services, culminating in a “staggering 880 people on its waitlist for psychiatric services,” The Washington Post October 29 reports. According to the article, Mass Gen had to issue a letter…

Read More

By: Tarsilla Moura
October 31, 2022
Share

House passes mental health parity bill to boost worker protection, impose fines

Editor's Note On Thursday, September 29, the House of Representatives voted 220-205 to pass legislation to impose new fines on insures that do not follow federal mental health pay parity requirements, in order to "hold employer-based health plans more accountable for improper denials of mental health and substance use benefits,"…

Read More

By: Tarsilla Moura
September 30, 2022
Share

Benefits seen in phase 3 of Alzheimer's drug trial

Editor's Note Eisai, the Japanese drug maker, said on Tuesday September 27, that its experimental drug for Alzheimer’s disease helped slow cognitive decline to those experiencing early stages of the illness. In the phase 3 clinical trials, the drug, called lecanemab, slowed cognitive decline by 27% after 18 months, the…

Read More

By: Lauren McCaffrey
September 28, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat